December 2015 Global Supplement - Endovascular Today

Table of Contents

Supplement

December 2015 Global Supplement

DCB Comes of Age

Durable. Consistent. Safe.

In This Supplement

Download PDF

IN.PACT SFA Trial: Overview of Study Design and 2-Year Clinical Outcomes

Sustained durability of IN.PACT™ Admiral™ DCB treatment effect with no late catch-up through 2 years.

By Peter A. Schneider, MD

IN.PACT Global Study: Overview and 12-Month Outcomes of the Long Lesion and In-Stent Restenosis Imaging Cohorts

Positive overall safety and effectiveness for patients treated with the IN.PACT™ Admiral™ drug-coated balloon.

By Marianne Brodmann, MD

The Role of Preclinical Data in Drug-Coated Balloon Therapy

Drs. Virmani and Granada explain the importance of preclinical data, discuss key parameters for evaluation, and review the science behind clinical performance.

With Renu Virmani, MD, and Juan F. Granada, MD, FACC

Perspectives on 2-Year Drug-Coated Balloon Data

A panel of experts discusses how the 2-year IN.PACT SFA and 1-year IN.PACT Global Study data affect decisions in real-world clinical practice.

With Marianne Brodmann, MD; John H. Rundback, MD, FAHA, FSVM, FSIR; Peter A. Schneider, MD; and Jos C. van den Berg, MD, PhD

Latest Issues

March 2026

February 2026

January 2026

December 2025

November 2025

View All Issues

In This Supplement

Most Read Articles